Abbvie Inc (NYSE:ABBV) Quickens Stake Buybacks Following Pharmacyclics, Inc. (NASDAQ:PCYC) Deal

On Wednesday, AbbVie Inc (NYSE:ABBV) announced that it would reacquire shares after the acquisition of Pharmacyclics, Inc. (NASDAQ:PCYC) was finalized. The company announced its plans to buy back stock worth $5 billion from Morgan Stanley. The announcement was made as soon as the acquisition was completed. The news that AbbVie had plans to acquire Pharmacyclics […]

Pharmacyclics, Inc. (NASSDAQ:PCYC) And Servier Strike Deal To End Collaboration On Pan-HDAC Inhibitor

Boston, MA 09/26/2014 (wallstreetpr) – Biopharmaceutical company, Pharmacyclics, Inc. (NASDAQ:PCYC) disclosed that it has struck an agreement with French pharmaceutical company, Servier, paving the way for ending the collaboration relating to pan-HDAC inhibitor compounds. Collaboration Ends The company said that the agreement was mutual and amicable, its statement indicated. As a result, abexinostat compound would […]

The FDA Approves Pharmacyclics, Inc. (NASDAQ:PCYC)’s Filing For Supplemental New Drug Application For Drug IMBRUVICA

Boston, MA 06/10/2014 (wallstreetpr) – Pharmacyclics, Inc. (NASDAQ:PCYC) announced that the U.S. Food and Drug Administration has agreed to file its supplemental New Drug Application in support of the review of its drug IMBRUVICA for the treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma for complete approval. The supplemental NDA is useful in the […]

Most Mentioned Stocks: Altria Group Inc (NYSE:MO), Health Care REIT, Inc. (NYSE:HCN), Pharmacyclics, Inc. (NASDAQ:PCYC)

Boston, MA 06/03/2014 (wallstreetpr) – Altria Group Inc (NYSE:MO) will pay a quarterly dividend of $0.48 per share on July 10, to shareholders who will have acquired its share by June 16. The newly declared quarterly dividend represents 4.73 percent on annualized basis.  The company has kept a good fight in the cigarette industry, and […]

Herein: GASTAR EXPLORATION, Inc. (NYSEMKT:GST), Pharmacyclics, Inc. (NASDAQ:PCYC), Bridgepoint Education Inc (NYSE:BPI)

Boston, MA 04/02/2014 (wallstreetpr) – GASTAR EXPLORATION, Inc. (NYSEMKT:GST) hosts equity analysts and investors today, where the company’s senior management will provide details about current and future operations plans. The management will particularly take analysts and investors through discussions on expanded drilling inventory in Marcellus Shale. The event takes place in Houston, Texas. The company’s CEO […]

Pharmacyclics-heading Uphill On Cancer Drug Push

Boston, MA 02/19/2013 (wallstreetpr)- Pharmacyclics, Inc (NASDAQ:PCYC) has been working in collaboration with Johnson & Johnson (NYSE:JNJ) on Ibrutinib, the leukemia and mantle cell lymphoma treatment drug. Late 2014 would see the launch of the very first drug that the company would be selling if it gets market approved by FDA. In 2012, FDA had […]